Publications

• Diagnosis and clinical management of drug allergies in obstetrics and gynecology: an expert review.Burn MS, Kwah JH, Son M. Am J Obstet Gynecol. 2025 Mar; 2024 Oct 28. PMID: 39490659.
• Decreased T helper 1 cell function underlies recurrent sinopulmonary infections in the 17q12 deletion syndrome.Shin JJ, Shin HJ, Gutierrez A, Yoo N, Par-Young J, Osmani L, Shin MS, Sanchez-Lara PA, Bucala R, Soffer G, Kang I. EBioMedicine. 2025 Feb; 2025 Feb 1. PMID: 39891996.
• The next frontier: Defining and optimizing treatments for patients with type 2 low asthma.Zidan E, Wilson G, Shin JJ, Chupp G. Ann Allergy Asthma Immunol. 2025 Jan; 2024 Oct 15. PMID: 39414022.
• IL-1 receptor 1 signaling shapes the development of viral antigen-specific CD4(+) T cell responses following COVID-19 mRNA vaccination.Park HJ, Shin MS, Shin JJ, Kim H, Kang B, Par-Young J, Unlu S, Afinogenova Y, Catanzaro J, Young J, Kim M, Lee SJ, Jeon S, You S, Racke MK, Bucala R, Kang I. EBioMedicine. 2024 May; 2024 Apr 18. PMID: 38640835.
• Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA. J Am Acad Dermatol. 2024 May; 2023 Jul 27. PMID: 37516359.
• Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA. J Am Acad Dermatol. 2024 May; 2023 Jul 28. PMID: 37516356.
• COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.McDonnell J, Cousins K, Younger MEM, Lane A, Abolhassani H, Abraham RS, Al-Tamemi S, Aldave-Becerra JC, Al-Faris EH, Alfaro-Murillo A, AlKhater SA, Alsaati N, Doss AMA, Anderson M, Angarola E, Ariue B, Arnold DE, Assa'ad AH, Aytekin C, Bank M, Bergerson JRE, Bleesing J, Boesing J, Bouso C, Brodszki N, Cabanillas D, Cady C, Callahan MA, Caorsi R, Carbone J, Carrabba M, Castagnoli R, Catanzaro JR, Chan S, Chandra S, Chapdelaine H, Chavoshzadeh Z, Chong HJ, Connors L, Consonni F, Correa-Jimenez O, Cunningham-Rundles C, D'Astous-Gauthier K, Delmonte OM, Demirdag YY, Deshpande DR, Diaz-Cabrera NM, Dimitriades VR, El-Owaidy R, ElGhazali G, Al-Hammadi S, Fabio G, Faure AS, Feng J, Fernandez JM, Fill L, Franco GR, Frenck RW, Fuleihan RL, Giardino G, Galant-Swafford J, Gambineri E, Garabedian EK, Geerlinks AV, Goudouris E, Grecco O, Pan-Hammarström Q, Khani HHK, Hammarström L, Hartog NL, Heimall J, Hernandez-Molina G, Horner CC, Hostoffer RW, Hristova N, Hsiao KC, Ivankovich-Escoto G, Jaber F, Jalil M, Jamee M, Jean T, Jeong S, Jhaveri D, Jordan MB, Joshi AY, Kalkat A, Kanarek HJ, Kellner ES, Khojah A, Khoury R, Kokron CM, Kumar A, Lecerf K, Lehman HK, Leiding JW, Lesmana H, Lim XR, Lopes JP, López AL, Tarquini L, Lundgren IS, Magnusson J, Marinho AKBB, Marseglia GL, Martone GM, Mechtler AG, Mendonca L, Milner JD, Mustillo PJ, Naderi AG, Naviglio S, Nell J, Niebur HB, Notarangelo L, Oleastro M, Ortega-López MC, Patel NR, Petrovic G, Pignata C, Porras O, Prince BT, Puck JM, Qamar N, Rabusin M, Raje N, Regairaz L, Risma KA, Ristagno EH, Routes J, Roxo-Junior P, Salemi N, Scalchunes C, Schuval SJ, Seneviratne SL, Shankar A, Sherkat R, Shin JJ, Siddiqi A, Signa S, Sobh A, Lima FMS, Stenehjem KK, Tam JS, Tang M, Barros MT, Verbsky J, Vergadi E, Voelker DH, Volpi S, Wall LA, Wang C, Williams KW, Wu EY, Wu SS, Zhou JJ, Cook A, Sullivan KE, Marsh R. J Clin Immunol. 2024 Apr 5; 2024 Apr 5. PMID: 38578389.
• Approaches to pandemic prevention - the chromatin vaccine.Zhang J, Askenase P, Jaenisch R, Crumpacker CS. Front Immunol. 2023; 2023 Dec 8. PMID: 38143744.
• Differences in Mortality Among Patients With Asthma and COPD Hospitalized With COVID-19.Liu Y, Rajeevan H, Simonov M, Lee S, Wilson FP, Desir GV, Vinetz JM, Yan X, Wang Z, Clark BJ, Possick JD, Price C, Lutchmansingh DD, Ortega H, Zaeh S, Gomez JV, Cohn L, Gautam S, Chupp GL. J Allergy Clin Immunol Pract. 2023 Nov; 2023 Jul 14. PMID: 37454926.
• Natural killer cell-mediated contact dermatitis-like reaction induced by treatment with TLR3 ligand poly(I:C).Majewska-Szczepanik M, Kowalczyk P, Askenase PW, Szczepanik M. Contact Dermatitis. 2023 Oct; 2023 Jul 18. PMID: 37463838.
• A safe, effective, and single-day protocol for rapid drug desensitization to intravenous iron dextran.Belmont A, Liao J, Hsu FI, Kwah J. J Allergy Clin Immunol Pract. 2023 Oct; 2023 Jun 15. PMID: 37329952.
• Editorial: Extracellular vesicles as potent modulators of immunity.Bryniarski K, Fernández-Messina L, Askenase PW, Nazimek K. Front Cell Dev Biol. 2023; 2023 Aug 28. PMID: 37701783.
• Evaluating the PEN-FAST Clinical Decision-making Tool to Enhance Penicillin Allergy Delabeling.Su C, Belmont A, Liao J, Kuster JK, Trubiano JA, Kwah JH. JAMA Intern Med. 2023 Aug 1. PMID: 37338869.
• Antibiotic choice for Group B Streptococcus prophylaxis in mothers with reported penicillin allergy and associated newborn outcomes.Snider JB, Mithal LB, Kwah JH, Rhodes NJ, Son M. BMC Pregnancy Childbirth. 2023 May 30; 2023 May 30. PMID: 37254067.
• Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis.Stone CA Jr, Robinson LB, Li L, Krantz MS, Kwah JH, Ortega G, Mancini C, Wolfson AR, Saff RR, Samarakoon U, Hong DI, Koo G, Chow TG, Gruchalla R, Liao JX, Kuster JK, Price C, Ahola C, Khan DA, Phillips EJ, Banerji A, Blumenthal KG. J Allergy Clin Immunol Pract. 2023 Feb; 2022 Sep 13. PMID: 36108922.
• Management of Steroid-Refractory Gastrointestinal Immune-Related Adverse Events.Brongiel S, Rychalsky KL, Luon D, Johnson AR, Price C, Abdelghany O. Ann Pharmacother. 2023 Feb; 2022 Jun 3. PMID: 35656843.
• Effect of Androgen-Androgen Receptor Directed Therapy on COVID-19 Outcome in Prostate Cancer Patients.Ünlü S, Shin JJ, Par-Young J, Simonov M, Vinetz J, Petrylak DP, Kang I, Kim JW. Cancer Invest. 2023 Jan; 2022 Nov 17. PMID: 36373994.
• Urgent desensitization for severe amiodarone intolerance with a 12-step protocol.Purtell C, Mehta M, Steele R, Schoenfeld M. J Cardiovasc Electrophysiol. 2022 Nov; 2022 Oct 2. PMID: 36150137.
• Systems Vaccinology in HIV Vaccine Development.Zhang J, Askenase P, Crumpacker CS. Vaccines (Basel). 2022 Sep 28; 2022 Sep 28. PMID: 36298489.
• Correction: Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.Hsu FI, Lumry W, Riedl M, Tachdjian R. Allergy Asthma Clin Immunol. 2022 Sep 3; 2022 Sep 3. PMID: 36057583.
• Outpatient penicillin allergy evaluation during pregnancy and associated clinical outcomes.Kwah JH, Burn MS, Liao J, Cate J, Son M. Am J Obstet Gynecol MFM. 2022 Sep; 2022 Jun 10. PMID: 35691578.
• Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency.Shin JJ, Par-Young J, Unlu S, McNamara A, Park HJ, Shin MS, Gee RJ, Doyle H, Afinogenova Y, Zidan E, Kwah J, Russo A, Mamula M, Hsu FI, Catanzaro J, Racke M, Bucala R, Wilen C, Kang I. J Clin Immunol. 2022 Aug; 2022 Jun 17. PMID: 35713752.
• Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age.Hsu FI, Lumry W, Riedl M, Tachdjian R. Allergy Asthma Clin Immunol. 2022 Jul 13; 2022 Jul 13. PMID: 35831891.
• Exosome Carrier Effects; Resistance to Digestion in Phagolysosomes May Assist Transfers to Targeted Cells; II Transfers of miRNAs Are Better Analyzed via Systems Approach as They Do Not Fit Conventional Reductionist Stoichiometric Concepts.Askenase PW. Int J Mol Sci. 2022 May 31; 2022 May 31. PMID: 35682875.
• Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency.Kuster JK, Unlu S, Makin TA, Par-Young J, Simonov M, Shafi S, Balanda M, Randolph C, Steele R, Hsu FI, Price C, Kohli-Pamnani A, Borish L, Lawrence MG, Kang I, Shin JJ. J Allergy Clin Immunol Pract. 2022 Feb; 2021 Dec 18. PMID: 34929372.
• Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.Jones DH, Bansal P, Bernstein JA, Fatteh S, Harper J, Hsu FI, O'Connor M, Park N, Suez D. World Allergy Organ J. 2022 Jan; 2022 Jan 27. PMID: 35145604.
• Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era.Wang SY, Juthani PV, Borges KA, Shallow MK, Gupta A, Price C, Won CH, Chun HJ. Lancet Microbe. 2022 Jan; 2021 Dec 3. PMID: 34901896.
• A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults.Shin JJ, Jeon S, Unlu S, Par-Young J, Shin MS, Kuster JK, Afinogenova Y, Kang Y, Simonov M, Buller G, Bucala R, Kang I. Clin Immunol. 2021 Nov; 2021 Sep 22. PMID: 34560283.
• Hospitalisation among vaccine breakthrough COVID-19 infections.Juthani PV, Gupta A, Borges KA, Price CC, Lee AI, Won CH, Chun HJ. Lancet Infect Dis. 2021 Nov; 2021 Sep 7. PMID: 34506735.
• Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose.Krantz MS, Kwah JH, Stone CA Jr, Phillips EJ, Ortega G, Banerji A, Blumenthal KG. JAMA Intern Med. 2021 Nov 1. PMID: 34309623.
• Exosomes provide unappreciated carrier effects that assist transfers of their miRNAs to targeted cells; I. They are 'The Elephant in the Room'.Askenase PW. RNA Biol. 2021 Nov; 2021 May 4. PMID: 33944671.
• Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.Askenase PW. N Engl J Med. 2021 Oct 28. PMID: 34706177.
• Immune Checkpoint Inhibitor-associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies.Tran AN, Wang M, Hundt M, Chugh R, Ohm J, Grimshaw A, Ciarleglio M, Hung KW, Proctor DD, Price CC, Laine L, Al-Bawardy B. J Immunother. 2021 Oct 1. PMID: 34380976.
• Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury.Nakazaki M, Morita T, Lankford KL, Askenase PW, Kocsis JD. J Extracell Vesicles. 2021 Sep. PMID: 34478241.
• Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Lee AI, Pine AB, Chun HJ, Zhang X, Fernandez-Hernando C, Qing H, Wang A, Price C, Sun Z, Utsumi T, Hwa J, Strazzabosco M, Iwakiri Y. J Hepatol. 2021 Sep; 2021 May 13. PMID: 33991637.
• Software for the frontiers of quantum chemistry: An overview of developments in the Q-Chem 5 package.Epifanovsky E, Gilbert ATB, Feng X, Lee J, Mao Y, Mardirossian N, Pokhilko P, White AF, Coons MP, Dempwolff AL, Gan Z, Hait D, Horn PR, Jacobson LD, Kaliman I, Kussmann J, Lange AW, Lao KU, Levine DS, Liu J, McKenzie SC, Morrison AF, Nanda KD, Plasser F, Rehn DR, Vidal ML, You ZQ, Zhu Y, Alam B, Albrecht BJ, Aldossary A, Alguire E, Andersen JH, Athavale V, Barton D, Begam K, Behn A, Bellonzi N, Bernard YA, Berquist EJ, Burton HGA, Carreras A, Carter-Fenk K, Chakraborty R, Chien AD, Closser KD, Cofer-Shabica V, Dasgupta S, de Wergifosse M, Deng J, Diedenhofen M, Do H, Ehlert S, Fang PT, Fatehi S, Feng Q, Friedhoff T, Gayvert J, Ge Q, Gidofalvi G, Goldey M, Gomes J, González-Espinoza CE, Gulania S, Gunina AO, Hanson-Heine MWD, Harbach PHP, Hauser A, Herbst MF, Hernández Vera M, Hodecker M, Holden ZC, Houck S, Huang X, Hui K, Huynh BC, Ivanov M, Jász Á, Ji H, Jiang H, Kaduk B, Kähler S, Khistyaev K, Kim J, Kis G, Klunzinger P, Koczor-Benda Z, Koh JH, Kosenkov D, Koulias L, Kowalczyk T, Krauter CM, Kue K, Kunitsa A, Kus T, Ladjánszki I, Landau A, Lawler KV, Lefrancois D, Lehtola S, Li RR, Li YP, Liang J, Liebenthal M, Lin HH, Lin YS, Liu F, Liu KY, Loipersberger M, Luenser A, Manjanath A, Manohar P, Mansoor E, Manzer SF, Mao SP, Marenich AV, Markovich T, Mason S, Maurer SA, McLaughlin PF, Menger MFSJ, Mewes JM, Mewes SA, Morgante P, Mullinax JW, Oosterbaan KJ, Paran G, Paul AC, Paul SK, Pavošević F, Pei Z, Prager S, Proynov EI, Rák Á, Ramos-Cordoba E, Rana B, Rask AE, Rettig A, Richard RM, Rob F, Rossomme E, Scheele T, Scheurer M, Schneider M, Sergueev N, Sharada SM, Skomorowski W, Small DW, Stein CJ, Su YC, Sundstrom EJ, Tao Z, Thirman J, Tornai GJ, Tsuchimochi T, Tubman NM, Veccham SP, Vydrov O, Wenzel J, Witte J, Yamada A, Yao K, Yeganeh S, Yost SR, Zech A, Zhang IY, Zhang X, Zhang Y, Zuev D, Aspuru-Guzik A, Bell AT, Besley NA, Bravaya KB, Brooks BR, Casanova D, Chai JD, Coriani S, Cramer CJ, Cserey G, DePrince AE 3rd, DiStasio RA Jr, Dreuw A, Dunietz BD, Furlani TR, Goddard WA 3rd, Hammes-Schiffer S, Head-Gordon T, Hehre WJ, Hsu CP, Jagau TC, Jung Y, Klamt A, Kong J, Lambrecht DS, Liang W, Mayhall NJ, McCurdy CW, Neaton JB, Ochsenfeld C, Parkhill JA, Peverati R, Rassolov VA, Shao Y, Slipchenko LV, Stauch T, Steele RP, Subotnik JE, Thom AJW, Tkatchenko A, Truhlar DG, Van Voorhis T, Wesolowski TA, Whaley KB, Woodcock HL 3rd, Zimmerman PM, Faraji S, Gill PMW, Head-Gordon M, Herbert JM, Krylov AI. J Chem Phys. 2021 Aug 28. PMID: 34470363.
• Challenges in interpreting cytokine data in COVID-19 affect patient care and management.Wang SY, Takahashi T, Pine AB, Damsky WE, Simonov M, Zhang Y, Kieras E, Price CC, King BA, Siegel MD, Desir GV, Lee AI, Iwasaki A, Chun HJ. PLoS Biol. 2021 Aug; 2021 Aug 6. PMID: 34358229.
• Antibodies Enhance the Suppressive Activity of Extracellular Vesicles in Mouse Delayed-Type Hypersensitivity.Nazimek K, Bustos-Morán E, Blas-Rus N, Nowak B, Totoń-Żurańska J, Seweryn MT, Wołkow P, Woźnicka O, Szatanek R, Siedlar M, Askenase PW, Sánchez-Madrid F, Bryniarski K. Pharmaceuticals (Basel). 2021 Jul 27; 2021 Jul 27. PMID: 34451831.
• Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy.Lo YC, Price C, Blenman K, Patil P, Zhang X, Robert ME. Am J Clin Pathol. 2021 Jul 6. PMID: 33555016.
• Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish ML, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O’Halloran JA, Presti RM, Kim AH, Gelman AE, Dela Cruz CS, Lee AI, Mudd PA, Chun HJ, Atkinson JP, Kulkarni HS. Sci Immunol. 2021 May 13. PMID: 34446527.
• Response.Price CC, Altice FL, Azar MM, McManus D, Gleeson SE, Britto CJ, Azmy V, Kaman K, Davis M, Chupp G, Bucala R, Kaminski N, Topal JE, Dela Cruz C, Malinis M. Chest. 2021 May. PMID: 33965143.
• Infectious Complications Predict Premature CD8(+) T-cell Senescence in CD40 Ligand-Deficient Patients.Shin JJ, Catanzaro J, Yonkof JR, Delmonte O, Sacco K, Shin MS, Reddy S, Whittington PJ, Soffer G, Mustillo PJ, Sullivan KE, Notarangelo LD, Abraham RS, Romberg N, Kang I. J Clin Immunol. 2021 May; 2021 Jan 26. PMID: 33495902.
• Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.Azmy V, Kaman K, Tang D, Zhao H, Dela Cruz C, Topal JE, Malinis M, Price CC. J Clin Immunol. 2021 May; 2021 Jan 18. PMID: 33459964.
• Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: A propensity score-matched analysis.Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, DeFilippo N, Keating C, Liu Y, Mankbadi M, McManus D, Wang SY, Price C, Bona RD, Ochoa Chaar CI, Chun HJ, Pine AB, Rinder HM, Siner JM, Neuberg DS, Owusu KA, Lee AI. Am J Hematol. 2021 Apr 1; 2021 Feb 22. PMID: 33476420.
• A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients.Ringer M, Azmy V, Kaman K, Tang D, Cheung H, Azar MM, Price C, Malinis M. Transpl Infect Dis. 2021 Apr; 2021 Jan 22. PMID: 33378571.
• A neutrophil activation signature predicts critical illness and mortality in COVID-19.Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun HJ. Blood Adv. 2021 Mar 9. PMID: 33635335.
• Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.Ma L, Sahu SK, Cano M, Kuppuswamy V, Bajwa J, McPhatter J, Pine A, Meizlish M, Goshua G, Chang CH, Zhang H, Price C, Bahel P, Rinder H, Lei T, Day A, Reynolds D, Wu X, Schriefer R, Rauseo AM, Goss CW, O'Halloran JA, Presti RM, Kim AH, Gelman AE, Cruz CD, Lee AI, Mudd P, Chun HJ, Atkinson JP, Kulkarni HS. bioRxiv. 2021 Feb 23; 2021 Feb 23. PMID: 33655244.
• Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis.Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, DeFilippo N, Keating C, Liu Y, Mankbadi M, McManus D, Wang S, Price C, Bona RD, Chaar CIO, Chun HJ, Pine AB, Rinder HM, Siner J, Neuberg DS, Owusu KA, Lee AI. medRxiv. 2021 Jan 15; 2021 Jan 15. PMID: 33469595.
• Cytokine profiles in severe SARS-CoV-2 infection requiring extracorporeal membrane oxygenation support.Kaman K, Azmy V, Chichra A, Britto-Leon C, Price C. Respir Med Case Rep. 2021; 2021 Mar 3. PMID: 33680800.
• Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease.Zhou Z, Price CC. Expert Opin Investig Drugs. 2020 Dec; 2020 Dec 1. PMID: 33094669.
• Circulating markers of angiogenesis and endotheliopathy in COVID-19.Pine AB, Meizlish ML, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan JM, Won CH, Price C, Dela Cruz CS, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ. Pulm Circ. 2020 Oct-Dec; 2020 Nov 25. PMID: 33282193.
• Optimizing Care for Patients With Adverse Events From Immunotherapeutics.Sheehan K, Price C, Hafez N. Cancer J. 2020 Nov/Dec. PMID: 33298725.
• Clinical presentation of hereditary angioedema.Azmy V, Brooks JP, Hsu FI. Allergy Asthma Proc. 2020 Nov 1. PMID: 33109320.
• Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.Azar MM, Shin JJ, Kang I, Landry M. Expert Rev Mol Diagn. 2020 Nov; 2020 Oct 12. PMID: 32990479.
• A 79-year-old man with persistent eosinophilia and elevated immunoglobulin E.Brooks JP, Harada K, K Le N, Steele R. Allergy Asthma Proc. 2020 Nov 1; 2020 Jul 23. PMID: 32703335.
• Idiopathic nonhistaminergic acquired angioedema in a patient with coronavirus disease 2019.Azmy V, Benson J, Love K, Steele R. Ann Allergy Asthma Immunol. 2020 Nov; 2020 Jul 1. PMID: 32621992.
• Repurposing antimicrobial stewardship tools in the electronic medical record for the management of COVID-19 patients.Davis MW, McManus D, Koff A, Jaszczur GR, Malinis M, Dela Cruz C, Britto CJ, Price C, Azmy V, Kaman K, Gaston D, Early K, DeWitt M, Song JS, Ortiz C, Juthani-Mehta M, Topal JE. Infect Control Hosp Epidemiol. 2020 Nov; 2020 Jun 8. PMID: 32507113.
• COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?Askenase PW. J Extracell Vesicles. 2020 Oct; 2020 Nov 14. PMID: 33304473.
• Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019: Survival and Clinical Outcomes.Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Chest. 2020 Oct; 2020 Jun 15. PMID: 32553536.
• Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains.Nazimek K, Bryniarski K, Ptak W, Groot Kormelink T, Askenase PW. Int J Mol Sci. 2020 Aug 2; 2020 Aug 2. PMID: 32748889.
• Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Lancet Haematol. 2020 Aug; 2020 Jun 30. PMID: 32619411.
• Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19.Meizlish ML, Pine AB, Goshua G, Chang CH, Zhang H, Bishai J, Bahel P, Patel A, Gbyli R, Kwan J, Price C, Cruz CSD, Halene S, van Dijk D, Hwa J, Lee AI, Chun HJ. medRxiv. 2020 Jul 1; 2020 Jul 1. PMID: 32637968.
• Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review.Brooks JP, Radojicic C, Riedl MA, Newcomer SD, Banerji A, Hsu FI. J Allergy Clin Immunol Pract. 2020 Jun; 2020 Apr 3. PMID: 32251736.
• Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum.Shin JJ, Liauw D, Siddiqui S, Lee J, Chung EJ, Steele R, Hsu FI, Price C, Kang I. J Clin Immunol. 2020 May; 2020 Apr 2. PMID: 32239366.
• Spectroscopic Signatures of Mode-Dependent Tunnel Splitting in the Iodide-Water Binary Complex.Talbot JJ, Yang N, Huang M, Duong CH, McCoy AB, Steele RP, Johnson MA. J Phys Chem A. 2020 Apr 16; 2020 Apr 2. PMID: 32162519.
• Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema.Valerieva A, Staevska M, Jesenak M, Hrubiskova K, Sobotkova M, Zachova R, Hakl R, Andrejevic S, Suiter T, Grivcheva-Panovska V, Karadza-Lapic L, Soteres D, Shapiro R, Rumbyrt J, Tachdjian R, Mehta V, Hsu FI, Zanichelli A. J Allergy Clin Immunol Pract. 2020 Feb; 2019 Aug 19. PMID: 31437566.
• Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.Brooks JP, Azmy V, Thompson A, Luon D, Prozora SD, Price C, Hsu FI. J Oncol Pharm Pract. 2020 Jan; 2019 Mar 18. PMID: 30885040.
• Syngeneic red blood cell-induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice.Nazimek K, Bustos-Morán E, Blas-Rus N, Nowak B, Ptak W, Askenase PW, Sánchez-Madrid F, Bryniarski K. Clin Exp Allergy. 2019 Nov; 2019 Aug 26. PMID: 31365154.
• Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis.George J, Bajaj D, Sankaramangalam K, Yoo JW, Joshi NS, Gettinger S, Price C, Farrell JJ. Pancreatology. 2019 Jun; 2019 May 2. PMID: 31076344.
• Delayed-Type Hypersensitivity Underlying Casein Allergy Is Suppressed by Extracellular Vesicles Carrying miRNA-150.Wąsik M, Nazimek K, Nowak B, Askenase PW, Bryniarski K. Nutrients. 2019 Apr 23; 2019 Apr 23. PMID: 31018604.
• Intravenously administered contact allergens coupled to syngeneic erythrocytes induce in mice tolerance rather than effector immune response.Nazimek K, Wąsik M, Askenase PW, Bryniarski K. Folia Med Cracov. 2019. PMID: 31180076.
• Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses.Romberg N, Le Coz C, Glauzy S, Schickel JN, Trofa M, Nolan BE, Paessler M, Xu ML, Lambert MP, Lakhani SA, Khokha MK, Jyonouchi S, Heimall J, Takach P, Maglione PJ, Catanzaro J, Hsu FI, Sullivan KE, Cunningham-Rundles C, Meffre E. J Allergy Clin Immunol. 2019 Jan; 2018 Jun 20. PMID: 29935219.
• Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà-Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B. J Allergy Clin Immunol. 2018 Dec; 2018 May 4. PMID: 29729943.
• Antibody Light Chains Dictate the Specificity of Contact Hypersensitivity Effector Cell Suppression Mediated by Exosomes.Nazimek K, Askenase PW, Bryniarski K. Int J Mol Sci. 2018 Sep 7; 2018 Sep 7. PMID: 30205452.
• Intravenously delivered mesenchymal stem cell-derived exosomes target M2-type macrophages in the injured spinal cord.Lankford KL, Arroyo EJ, Nazimek K, Bryniarski K, Askenase PW, Kocsis JD. PLoS One. 2018; 2018 Jan 2. PMID: 29293592.
• Corrigendum to "Epicutaneous immunization with phosphorylcholine conjugated to bovine serum albumin (PC-BSA) and TLR9 ligand CpG alleviates pneumococcal pneumonia in mice" [Pharmacol. Rep. 66 (2014) 570-575].Majewska-Szczepanik M, Yamamoto N, Askenase PW, Szczepanik M. Pharmacol Rep. 2017 Jun; 2017 Mar 29. PMID: 28365257.
• A novel community driven software for functional enrichment analysis of extracellular vesicles data.Pathan M, Keerthikumar S, Chisanga D, Alessandro R, Ang CS, Askenase P, Batagov AO, Benito-Martin A, Camussi G, Clayton A, Collino F, Di Vizio D, Falcon-Perez JM, Fonseca P, Fonseka P, Fontana S, Gho YS, Hendrix A, Hoen EN, Iraci N, Kastaniegaard K, Kislinger T, Kowal J, Kurochkin IV, Leonardi T, Liang Y, Llorente A, Lunavat TR, Maji S, Monteleone F, Øverbye A, Panaretakis T, Patel T, Peinado H, Pluchino S, Principe S, Ronquist G, Royo F, Sahoo S, Spinelli C, Stensballe A, Théry C, van Herwijnen MJC, Wauben M, Welton JL, Zhao K, Mathivanan S. J Extracell Vesicles. 2017; 2017 May 26. PMID: 28717418.
• The cationic small molecule GW4869 is cytotoxic to high phosphatidylserine-expressing myeloma cells.Vuckovic S, Vandyke K, Rickards DA, McCauley Winter P, Brown SHJ, Mitchell TW, Liu J, Lu J, Askenase PW, Yuriev E, Capuano B, Ramsland PA, Hill GR, Zannettino ACW, Hutchinson AT. Br J Haematol. 2017 May; 2017 Feb 17. PMID: 28211573.
• Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy.Pagovich OE, Wang B, Chiuchiolo MJ, Kaminsky SM, Sondhi D, Jose CL, Price CC, Brooks SF, Mezey JG, Crystal RG. J Allergy Clin Immunol. 2016 Dec; 2016 Jun 29. PMID: 27372563.
• Epicutaneous immunization with ovalbumin and CpG induces TH1/TH17 cytokines, which regulate IgE and IgG2a production.Majewska-Szczepanik M, Askenase PW, Lobo FM, Marcińska K, Wen L, Szczepanik M. J Allergy Clin Immunol. 2016 Jul; 2016 Jan 22. PMID: 26810716.
• Previously undiagnosed fatal familial haemophagocytic lymphohistiocytosis in a 24-year-old woman.Barmettler S, Nowak RJ, Parker T, Price C. BMJ Case Rep. 2016 Feb 22; 2016 Feb 22. PMID: 26903364.
• Expression of activation-induced cytidine deaminase enhances the clearance of pneumococcal pneumonia: evidence of a subpopulation of protective anti-pneumococcal B1a cells.Yamamoto N, Kerfoot SM, Hutchinson AT, Dela Cruz CS, Nakazawa N, Szczepanik M, Majewska-Szczepanik M, Nazimek K, Ohana N, Bryniarski K, Mori T, Muramatsu M, Kanemitsu K, Askenase PW. Immunology. 2016 Jan. PMID: 26456931.
• Typical evanescent and atypical persistent polymorphic cutaneous rash in an adult Brazilian with Still's disease: a case report and review of the literature.Michailidou D, Shin J, Forde I, Gopalratnam K, Cohen P, DeGirolamo A. Auto Immun Highlights. 2015 Dec; 2015 Sep 30. PMID: 26423534.
• Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?Barmettler S, Price C. J Allergy Clin Immunol. 2015 Nov; 2015 Aug 12. PMID: 26277594.
• From Mysterious Supernatant Entity to miRNA-150 in Antigen-Specific Exosomes: a History of Hapten-Specific T Suppressor Factor.Ptak W, Nazimek K, Askenase PW, Bryniarski K. Arch Immunol Ther Exp (Warsz). 2015 Oct; 2015 Feb 18. PMID: 25690461.
• Macrophages play an essential role in antigen-specific immune suppression mediated by T CD8⁺ cell-derived exosomes.Nazimek K, Ptak W, Nowak B, Ptak M, Askenase PW, Bryniarski K. Immunology. 2015 Sep; 2015 Apr 27. PMID: 25808106.
• Diagnostic and therapeutic potentials of exosomes in CNS diseases.Kawikova I, Askenase PW. Brain Res. 2015 Aug 18; 2014 Oct 7. PMID: 25304360.
• Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells.Bryniarski K, Ptak W, Martin E, Nazimek K, Szczepanik M, Sanak M, Askenase PW. PLoS One. 2015; 2015 Apr 29. PMID: 25923429.
• Epicutaneous immunization with phosphorylcholine conjugated to bovine serum albumin (PC-BSA) and TLR9 ligand CpG alleviates pneumococcal pneumonia in mice.Majewska-Szczepanik M, Yamamoto N, Askenase PW, Szczepanik M. Pharmacol Rep. 2014 Aug; 2014 Apr 26. PMID: 24948056.
• Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.Otremba MD, Adam SI, Price CC, Hohuan D, Kveton JF. Am J Otolaryngol. 2012 Sep-Oct; 2012 Feb 21. PMID: 22361345.
• The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.Menard L, Saadoun D, Isnardi I, Ng YS, Meyers G, Massad C, Price C, Abraham C, Motaghedi R, Buckner JH, Gregersen PK, Meffre E. J Clin Invest. 2011 Sep; 2011 Aug 1. PMID: 21804190.
• Mixed time slicing in path integral simulations.Steele RP, Zwickl J, Shushkov P, Tully JC. J Chem Phys. 2011 Feb 21. PMID: 21341833.
• Ab initio molecular dynamics with dual basis set methods.Steele RP, Head-Gordon M, Tully JC. J Phys Chem A. 2010 Nov 4. PMID: 20939545.
• How the shape of an H-bonded network controls proton-coupled water activation in HONO formation.Relph RA, Guasco TL, Elliott BM, Kamrath MZ, McCoy AB, Steele RP, Schofield DP, Jordan KD, Viggiano AA, Ferguson EE, Johnson MA. Science. 2010 Jan 15. PMID: 20075247.
• Identification of initiator B cells, a novel subset of activation-induced deaminase-dependent B-1-like cells that mediate initiation of contact sensitivity.Kerfoot SM, Szczepanik M, Tung JW, Askenase PW. J Immunol. 2008 Aug 1. PMID: 18641308.
• c-Jun NH2-terminal kinase 2 inhibits gamma interferon production during Anaplasma phagocytophilum infection.Pedra JH, Mattner J, Tao J, Kerfoot SM, Davis RJ, Flavell RA, Askenase PW, Yin Z, Fikrig E. Infect Immun. 2008 Jan; 2007 Nov 12. PMID: 17998313.
• Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity.Campos RA, Szczepanik M, Itakura A, Lisbonne M, Dey N, Leite-de-Moraes MC, Askenase PW. Immunology. 2006 Apr. PMID: 16556268.
• Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1.Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galán JE, Askenase PW, Flavell RA. Immunity. 2006 Mar. PMID: 16546100.
• An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity.Itakura A, Szczepanik M, Campos RA, Paliwal V, Majewska M, Matsuda H, Takatsu K, Askenase PW. J Immunol. 2005 Dec 1. PMID: 16301620.
• TLR-dependent IL-4 production by invariant Valpha14+Jalpha18+ NKT cells to initiate contact sensitivity in vivo.Askenase PW, Itakura A, Leite-de-Moraes MC, Lisbonne M, Roongapinun S, Goldstein DR, Szczepanik M. J Immunol. 2005 Nov 15. PMID: 16272291.